HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tiziana Mennini Selected Research

9- carboxymethyl- 4- oxo- 5H,10H- imidazo(1,2- a)indeno(1,2- e)pyrazin- 2- phosphonic acid

3/2006Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tiziana Mennini Research Topics

Disease

7Neurodegenerative Diseases (Neurodegenerative Disease)
09/2012 - 10/2003
5Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
06/2012 - 11/2002
5Inflammation (Inflammations)
05/2012 - 10/2002
4Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2012 - 07/2006
4Gliosis
06/2010 - 10/2006
4Ischemia
08/2008 - 09/2003
3Neuroinflammatory Diseases
09/2012 - 03/2006
3Seizures (Absence Seizure)
06/2012 - 02/2005
3Catalepsy
01/2009 - 01/2002
3Brain Ischemia (Cerebral Ischemia)
05/2005 - 10/2002
2Muscular Atrophy (Muscle Atrophy)
08/2012 - 03/2006
2Blindness (Hysterical Blindness)
06/2012 - 01/2011
2Epilepsy (Aura)
01/2011 - 02/2005
2Cognitive Dysfunction
01/2011 - 01/2004
2Central Nervous System Diseases (CNS Diseases)
11/2008 - 01/2007
2Multiple Sclerosis
11/2008 - 03/2006
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2008 - 10/2002
2Infarction (Infarctions)
03/2007 - 05/2005
1Intellectual Disability (Idiocy)
06/2012
1Decapitation
12/2010
1Pain (Aches)
06/2010
1Disease Progression
06/2010
1Mitochondrial Diseases (Mitochondrial Disease)
11/2009
1Motor Neuron Disease (Primary Lateral Sclerosis)
09/2009
1Obesity
01/2009
1Hypoxia (Hypoxemia)
11/2008
1Wounds and Injuries (Trauma)
08/2008
1Ischemic Stroke
08/2008
1Papilledema
08/2008
1Nervous System Diseases (Neurological Disorders)
03/2008
1Transient Ischemic Attack
03/2007
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
03/2007
1Encephalomyelitis (Myeloencephalitis)
03/2006
1Ganglion Cysts (Ganglion)
07/2004
1Depressive Disorder (Melancholia)
07/2004
1Astrocytoma (Pilocytic Astrocytoma)
07/2004
1Heart Failure
12/2002
1Traumatic Brain Injuries (Traumatic Brain Injury)
10/2002

Drug/Important Bio-Agent (IBA)

6ErythropoietinFDA Link
11/2008 - 10/2002
4Glutamic Acid (Glutamate)FDA Link
12/2010 - 10/2003
4CytokinesIBA
11/2008 - 09/2003
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008 - 09/2003
3Interleukin-6 (Interleukin 6)IBA
07/2004 - 10/2002
2RiluzoleFDA LinkGeneric
08/2012 - 03/2006
2lipopigmentsIBA
06/2012 - 01/2011
2Glutamine (L-Glutamine)FDA Link
12/2010 - 11/2009
2Kainic Acid (Kainate)IBA
12/2010 - 02/2005
2Pharmaceutical PreparationsIBA
06/2010 - 03/2008
2Antipsychotic Agents (Antipsychotics)IBA
01/2009 - 01/2002
2Interleukin-8 (Interleukin 8)IBA
03/2007 - 01/2007
2reparixinIBA
03/2007 - 05/2005
2alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
10/2006 - 03/2006
1Toll-Like Receptor 4IBA
09/2012
1gamma-Aminobutyric Acid (GABA)IBA
12/2010
1Acetates (Acetic Acid Esters)FDA Link
12/2010
1Glucose (Dextrose)FDA LinkGeneric
12/2010
1Analgesics (Analgesic Drugs)IBA
06/2010
1Liver X ReceptorsIBA
06/2010
1CholesterolIBA
06/2010
1Proteins (Proteins, Gene)FDA Link
11/2009
1Neuroprotective AgentsIBA
11/2009
1D-Aspartic Acid (D Aspartate)IBA
09/2009
1Serotonin AgentsIBA
01/2009
1Dopamine (Intropin)FDA LinkGeneric
01/2009
1Serotonin (5 Hydroxytryptamine)IBA
01/2009
1endothelial PAS domain-containing protein 1IBA
11/2008
1Messenger RNA (mRNA)IBA
11/2008
1Transcription Factors (Transcription Factor)IBA
11/2008
1Peptides (Polypeptides)IBA
08/2008
1Amino AcidsFDA Link
08/2008
1Type I Tumor Necrosis Factor ReceptorsIBA
03/2008
1ChemokinesIBA
01/2007
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2006
1AMPA Receptors (AMPA Receptor)IBA
10/2006
12,3- dimethyl- 6- phenyl- 12H- (1,3)dioxolo(4,5- h)imidazo(1,2- c)(2,3)benzodiazepineIBA
10/2006
1carbamylated erythropoietinIBA
07/2006
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
03/2006
19- carboxymethyl- 4- oxo- 5H,10H- imidazo(1,2- a)indeno(1,2- e)pyrazin- 2- phosphonic acidIBA
03/2006
1Peroxidase (Myeloperoxidase)IBA
05/2005
1Anticonvulsants (Antiepileptic Drugs)IBA
02/2005
1Retinaldehyde (Retinal)IBA
07/2004
1SaltsIBA
07/2004
1Antidepressive Agents (Antidepressants)IBA
07/2004
1hyperforinIBA
07/2004
1Substance PIBA
07/2004
1dicyclohexylamineIBA
07/2004
1ProlactinIBA
01/2004
1Phencyclidine (Angel Dust)IBA
01/2004
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2003
1AldosteroneIBA
12/2002
1Mineralocorticoid Receptor AntagonistsIBA
12/2002
1Glutamate Receptors (Glutamate Receptor)IBA
11/2002
1AntibodiesIBA
10/2002
1Glial Fibrillary Acidic ProteinIBA
10/2002

Therapy/Procedure

5Therapeutics
05/2012 - 10/2003
1Stem Cell Transplantation
05/2012